Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
| Revenue (TTM) | $1.46B |
| Gross Profit (TTM) | $473.02M |
| EBITDA | $228.84M |
| Operating Margin | 14.70% |
| Return on Equity | 31.80% |
| Return on Assets | 8.34% |
| Revenue/Share (TTM) | $36.13 |
| Book Value | $8.20 |
| Price-to-Book | 6.85 |
| Price-to-Sales (TTM) | 1.50 |
| EV/Revenue | 2.031 |
| EV/EBITDA | 13.73 |
| Quarterly Earnings Growth (YoY) | 752.00% |
| Quarterly Revenue Growth (YoY) | 20.90% |
| Shares Outstanding | $20.62M |
| Float | $20.40M |
| % Insiders | 1.01% |
| % Institutions | 97.19% |
Volatility is currently expanding